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INTRODUCTION
The Eustachian tube (ET) equalizes pressure between the middle ear and the nasopharynx and drains accumulated secretions 
from the middle ear. If the ET function is compromised, symptoms such as aural fullness, feeling of pressure, pain, clogged feeling, 
or popping in the ears may appear [1]. Chronic Eustachian tube dysfunction (ETD) may lead to recurrent or persistent otitis media 
with effusion (OME), hearing loss, temporary lag in speech development in children, retraction of the tympanic membrane, or even 
cholesteatoma [2]. Balloon Eustachian tuboplasty (BET) aims to prevent, reverse, or stop the progression of these conditions by 
widening the medial cartilaginous part of the ET, hence improving its function. Since its introduction in patients in 2010 [3], several 
studies on the effect of BET have been published. However, study populations tend to be small, and follow-up times are mostly 
short. Also, the heterogeneity of the studies with regard to indications, duration of follow-ups, and outcome measures complicates 
comparison of the results.
UK National Institute for Health Research Health Technology Assessment Program commissioned a review of treatments for ETD. 
The review found that the evidence of BET outcomes was insufficient to show efficacy and pointed the need for consensus on 
definition and diagnostic criteria of ETD [4]. To reach a consensus on these subjects, an international panel gathered in Amsterdam 
in June 2014. They concluded that the clinical assessment of ETD should include otoscopy/otomicroscopy, tympanometry, tuning 
fork tests or pure tone audiometry, and nasopharyngoscopy. The diagnosis of ETD should include ETD symptoms and negative 
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pressure in the middle ear observed either in the tympanogram or as 
a retraction of the tympanic membrane [1]. Additional tools for evalu-
ating ETD and the effect of BET include Valsalva and Toynbee maneu-
vers, tubomanometry, Eustachian Tube Score (ETS), ETS-7 (extension 
of ETS), and Eustachian Tube Dysfunction Questionnaire (ETDQ-7) 
[3,5-7]. However, till date, there is no gold standard for measuring BET 
outcomes.
Since no international consensus for the indications of BET has been 
reached, the Finnish Otosurgical Society agreed on proposed indica-
tions in its annual meeting held in April 2016. The indications were 
based on a review of ET physiology, middle ear aeration mechanisms, 
studies on BET outcome, and voting and discussion of patient cases 
related to ETD and BET. 
This report aims to summarize the current evidence of the long-term 
(≥12 months) effects of BET and present indications for the proce-
dure as proposed by the Finnish Otosurgical Society. 
METHODS
As the literature search for the meeting of the Finnish Otosurgical 
Society was performed in 2016, we wished to update the search 
when starting to work with this manuscript. Therefore, we scanned 
the PubMed and Scopus on May 24, 2017 using the keywords ‘‘Eu-
stachian tube’ AND ‘balloon’, ‘Eustachian’ AND ‘balloon dilation’, 
‘Eustachian’ AND ‘balloon dilatation’, and ‘Balloon Eustachian tubo-
plasty’ (Fig. 1). The search resulted in 100 individual articles. The 
inclusion criteria were full-text articles available in English with a 
minimum of 12-month follow-up. Exclusion criteria included ar-
ticles in language other than English (n=24), articles unrelated to 
ET (4), cadaver or animal studies (18), reviews (5), editorial or other 
short correspondences (4), transtympanic BET (3), case reports (3), 
studies with no follow-up (16), and follow-up <12 months or un-
clear (18). Since only five studies fulfilled the 12-month follow-up 
criterion, we also accepted studies (five articles) with follow-up of 
6–11 months as supportive information. Studies on both adults and 
children, separately or mixed, were included.
From the studies that met the inclusion criteria, we extracted the fol-
lowing information: study setting, number of patients and ears treat-
ed, number of drop-outs, age of patients, follow-up duration, type 
of balloon dilation catheter, surgical technique, type of anesthesia, 
inclusion and exclusion criteria, preoperative investigations, other 
procedures performed simultaneously with BET or during follow-up, 
conservative treatment given preoperatively or postoperatively, out-
come measures, and complications.
Outcome measures of BET
Since there is no consensus on the optimal outcome measures of 
BET, different studies have used different parameters. To help to com-
prehend the results, we have listed the main outcome measures used 
and their rationale below. 
Symptoms and Disease-Specific Questionnaire ETDQ-7
Typical ear symptoms suggestive of ETD include fullness, pressure, 
pain, clogged feeling, and popping [1]. Even though no symptom is 
specific to ETD alone and differential diagnostics has to be careful-
ly considered, symptoms have an important role in the diagnosis of 
ETD together with clinical findings.
ETDQ-7 is a validated, disease-specific questionnaire for ETD diag-
nosis. It also serves in the evaluation of treatment effect when used 
both pre and postoperatively. From the previous month, patients 
rate the severity of seven symptoms that are suggestive of ETD on a 
scale ranging from 1 (no problem) to 7 (severe problem). Dividing the 
total score by seven yields the mean item score. A total score of ≥14.5 
and mean item score of ≥2.1 indicate ETD [6]. 
Valsalva and Toynbee Maneuvers
In Valsalva maneuver, closing the nose and mouth while blowing 
air directs the air to the ETs and is supposed to help the ETs open. 
Toynbee maneuver is positive when the tympanic membrane moves 
while the patient swallows with the nose closed. Swallowing involves 
the muscles tensor veli palatini and levator veli palatini that simulta-
neously also act to open the ET. Positive Valsalva and Toynbee ma-
neuvers require at least a partly functional ET. Therefore, if positive, 
the maneuvers may serve as signs of ET function. However, Valsalva 
maneuver might be difficult to perform even with perfectly function-
ing ETs, and if Valsalva remains negative it is difficult for the examiner 
to ensure that the patient performs the maneuver correctly. There-
fore, with negative Valsalva, the examiner remains with the question 
whether the result is negative because of poor technique or whether 
it is negative because ET does not open despite correctly performed 
Valsalva. To conclude, the maneuvers by themselves are unreliable 
measures of ET function but they provide supporting information in 
the diagnostics of ETD [1]. The maneuvers can be measured objective-
ly with the help of oto(micro)scopy, impedance measurements, or 
sound recordings.
Tympanometry
Tympanometry provides information on the middle ear pressure, 
which, if negative, reflects ETD or other middle ear pathology. 
However, normal middle ear pressure does not exclude baro-chal-
lenge-induced ETD.
Computed Tomography (CT) Scans
The main purpose of preoperative computed tomography (CT) scans 
has mainly been to exclude dehiscence or anomaly of the internal 
carotid artery and thereby avoid complications involving damage to 
the internal carotid artery.Figure 1. Flowchart for the literature search performed on May 24, 2017
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Tubomanometry
Tubomanometry measures the latency of ET opening after swallow-
ing [7]. The subject swallows water while 30, 40, or 50 mbar pressure is 
applied through the nose. A pressure sensor in the external ear canal 
registers changes in pressure when the ET opens. Opening latency 
index (R value) of ≤1 suggests immediate opening of the ET after 
swallowing, R>1 reflects late opening, and non-measurable R indi-
cates that the ET stays closed.
ETS and ETS-7
ETS combines tubomanometry at three pressure levels with subjec-
tively positive Valsalva maneuver and clicking sound when swallow-
ing [5]. The subjective Valsalva and clicking sound when swallowing 
are evaluated from the period of previous two months. Each param-
eter receives a value from 0 (the worst) to 2 (the best) yielding mini-
mum and maximum total score of 0 and 10, respectively. ETS-7 adds 
the tympanometry and the objectively evaluated Valsalva to ETS and 
its score ranges from 0 (the worst value) to 14 (the best value) [5]. An 
ETS≤5 and ETS-7≤7 suggest diagnosis of chronic ETD.
Workshop To Define The Proposed Indications For BET By The Finn-
ish Otosurgical Society
In the annual meeting of the Finnish Otosurgical Society held in April 
2016 (Pallas, Finland), we covered ET physiology, middle ear venti-
lation mechanisms, and transmucosal gas exchange in the middle 
ear and the mastoid. We also reviewed studies on the effects of BET 
published so far in English and the consensus statement on ETD [1]. 
After agreeing on the diagnostic criteria of ETD, we reviewed 14 imag-
inary cases, of both adults and children, having different signs and 
symptoms related to ETD. The cases, translated to English, are in the 
Supplementary File 1. On the basis of their personal experience and 
the current literature, the members of the Finnish Otosurgical Society 
individually voted on each case whether they considered BET to be 
indicated or not or whether they were unable to decide. The voting 
proceeded with personal mobile phones and the Kahoot application 
(https://kahoot.it). The votes were divided into three different catego-
ries: (i) ENT specialists routinely performing BET (n=15), (ii) ENT special-
ists irregularly performing BET (n=6), and (iii) ENT residents (n=5). The 
voting results are shown in Supplementary Table 1. After voting, each 
case and the result of the vote were discussed before proceeding to 
the next case. After discussing all the cases, we agreed on proposed 
indications for BET, which are presented in the section “The proposed 
indications for BET by the Finnish Otosurgical Society”.
REVIEW of LITERATURE
Studies With Follow-Up Period Of ≥12 Months
Study Characteristics 
Five studies fulfilled the inclusion criteria. Maximal follow-up periods 
ranged between 12 and 50 months, and the number of patients and 
their outcome at ≥12 month time points were clearly identifiable. 
Two of the studies were prospective case series [8, 9], and the rest were 
retrospective case series [2, 10, 11]. The level of evidence according to 
Oxford Centre for Evidence-based Medicine was 4 in all studies. All 
the studies included a total of 968 patients (i.e., 1615 ears were treat-
ed with BET), but 1 year postoperatively, the loss to follow-up was 
>70% in three studies [2, 9, 10]. The patients were 3–88 years old; mean 
or median age, if reported, was 7–48 years. Four studies performed 
BET with balloon dilation instrument from Spiggle & Theis (Spiggle 
& Theis Medizintechnik GmbH, Overath, Germany) [2, 9-11]. One study 
used Acclarent Relieva Solo catheter (Acclarent Inc., Menlo Park, CA, 
USA) [8]. Inflation pressures ranged from 8 to 12 bars. All studies using 
Spiggle & Theis device kept the balloon inflated for 2 min at once. 
Silvola et al. [8] started with 1-min inflation for the first 15 ears but the 
rest 26 ears received 1-min dilation two times in a row. The Acclar-
ent device was wider and shorter than the one from Spiggle & Theis 
(7×16 mm vs. 3.2–3.3×20 mm, respectively). The findings are listed 
in Table 1a.
Inclusion and Exclusion Criteria And Preoperative Examinations 
The inclusion criteria varied between the studies. One study includ-
ed patients with ETD symptoms refractory to the conservative treat-
ment and required no objective findings of negative pressure in the 
middle ear [9]. Another study involved patients with ETD symptoms 
together with evidence of normal tympanic membrane for at least 
6 months preoperatively [11]. Two studies required an objective sign 
of negative pressure in the middle ear but no symptoms [2, 8]. In one 
retrospective study, the indications for BET changed during the 
chosen time frame of the analysis [10]. Three studies reported exclu-
sion criteria but they were different in each study [2, 9, 11]. The findings 
are listed in Table 1b.
Four studies required that, before proceeding to BET, conservative 
treatment had been given but that its effect was inadequate [2, 8, 9, 11]. 
The prerequisite treatment modalities varied from decongestive na-
sal sprays to adenotomy. The most common conservative treatment 
was nasal corticosteroids which was reported in three studies [8, 9, 11]. 
The minimum duration of the preoperative conservative treatment 
was 1-6 months. Two studies reported no duration for the conser-
vative treatment [2, 9]. In one of them, patients had received tympa-
nostomy and adenotomy before the evaluation of the effect of the 
conservative treatment, but the type of the conservative treatment 
used was unspecified [2]. 
The combinations of preoperative examinations were different in the 
five studies even though some overlap of the methods used existed 
between the studies. None of the studies used all preoperative inves-
tigation methods at the control visits. Otomicroscopy/otoscopy/clin-
ical examination was the only preoperative investigation included 
in all the studies. Three of the five studies performed a preoperative 
radiologic examination [8, 9, 11].
Other Operations, Corticosteroid Treatment, and Complications 
Two studies reported no other operations than BET at the time when 
BET was performed. [10, 11]. Others provided grommets at the time of 
BET if the tympanic membrane was intact [8] or tympanocenthesis or 
tympanoplasty to a part of the study population [2, 9]. Some patients 
received tympanoplasty before BET and others in conjunction with 
BET. Indications for tympanocenthesis or tympanoplasty remained un-
clear. One study reported additional procedures during the follow-up 
for 10% of the patients because they experienced no benefit from BET 
[8]. Four studies performed revision BET in 2%–11% of their patients 
because no improvement was observed following the first BET [2,8-10]. 
Four studies used corticosteroids preoperatively or postoperatively or 
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Table 1a. Characteristics of studies with a follow-up period of minimum 12 months
 Study Level of  n n Age (years)  Follow-up Dilation instrument; 
Publication setting evidence (patients) (ears) (mean) [range] (months) [range] inflation pressure and time
Silvola et al.,  Prospective 4 37 42 48 Mean 30, Acclarent Relieva Solo 7×16 mm; 
2014 [8] case series  (36 at the end  (41 at the end [15–38] [18–50] 15 cases 12 bar, 1 min, 
   of the follow-up) of the follow-up)    26 cases 12 bar 1 minx2 
Schröder et al.,  Retrospective 4 622 Total 1076 No mean [2–48] Spiggle & Theis 3.3x20 mm; 
2015 [10] case series   2 months: 506 of 1029 reported  10 bar, 2 min 
    1 year: 188 of 671 [7–84]
    2 years: 34 of 344
    3 years: 11 of 119
    4 years: 2 of 17   
Dalchow et al.,  Prospective 4 Total 217 342 Median 46 [1–12] Spiggle & Theis 3.3x20 mm; 
2016 [9] case series  1 month: 175  [6–88]  10 bar, 2 min
   3 months: 92
   6 months: 43
   9 months: 29
   12 months: 19     
  
Xiong et al.,  Retrospective 4 40 58 42 12 Spiggle & Theis 3.3x20 mm; 
2016 [11] case series    [21–70]  10 bar, 2 min
Leichtle et al.,  Retrospective 4 Total 52 97 7 [0–12] Spiggle & Theis, 3.2x20 mm; 
2017 [2] case series  2 weeks: 41  [3–15]  8 bar, 2 min 
   2 months: 38
   6 months: 27
   12 months: 14
Table 1b. Inclusion and exclusion criteria, preoperative examination in studies with follow-up period of minimum 12 months
Publication Inclusion criteria Exclusion criteria Preoperative examination
Silvola et al., 2014 [8] Uni or bilateral persistent OME or remarkable  NR Otomicroscopy, video endoscopy of the 
 nonadherent atelectasis of the TM for min 5 years;   nose, nasopharynx and ET orifices, 
 findings refractory to nasal corticosteroid treatment   objective Valsalva (with/without the help 
 of minimum 1 month  of Politzer balloon), CT
Schröder et al., 2015 [10] 1. ETD symptoms or previous middle ear surgery  NR Symptoms, ETDQ-7, history of ear diseases 
 because of undiagnosed ETD or chronic persistent OME  and previous ear surgery 
 2. ETS≤5 or ETS-7≤7 and at least one of the following:   clinical examination, Valsalva,     
 pressure in the ear (especially during changes of   Toynbee, tympanometry,  
 atmospheric pressure), inability to do Valsalva,   TMM, audiometry 
 chronic middle ear effusion, adhesive otitis media,    
 tympanometry type B, early retraction after repair  
 of tympanic membrane   
Dalchow et al., 2016 [9] Symptoms of chronic obstructive ETD refractory to  Revision BET Pressure in the ear, otomicroscopy, 
 detumescent nasal sprays with or without cortisone,   nasopharyngoscopy, Valsalva, Toynbee, 
 systemic cortisone or tube training  tympanometry, TMM, audiometry, digital  
   volume tomography
Xiong et al., 2016 [11] Aural fullness with or without otalgia, muffled  TMJ problems, Symptoms, otoscopy, Valsalva, ETS, TMM, 
 hearing and tinnitus, normal TM for minimum  endolymphatic hydrops, audiometry, impedance audiometry, 
 6 months preoperatively; symptoms refractory to  OME, TM atelectasis, history HRCT 
 minimum 6 months autoinsufflation, nasal  of any middle ear disease 
 decongestants, antihistamines, and nasal  
 corticosteroids   
Leichtle et al., 2017 [2] Persistent/recurrent otitis media with or without  Acute upper respiratory Lübecker questionnaire, clinical 
 chronic middle ear effusion or chronic adhesions  tract infection, cleft palate, examination, tympanometry, TMM at 50 
 with poorly mobile tympanic membrane, persistent  other craniofacial mbar, audiometry/children’s audiometry 
 perforation of the TM or cholesteatoma; clinical  malformation 
 findings refractory to conventional therapy after  
 adenotomy and tympanostomy  
BET, balloon Eustachian tuboplasty; CT, computed tomography; ET, Eustachian tube; ETD, Eustachian tube dysfunction; ETDQ-7, Eustachian Tube Dysfunction Questionnaire; ETS, 
Eustachian Tube Score; ETS-7, extended Eustachian Tube Score; HRCT, high resolution computed tomography; NR, not reported; OME, otitis media with effusion; TM, tympanic mem-
brane; TMJ, temporomandibular joint; TMM, tubomanometry.
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both [8–11]; duration of the corticosteroid treatment varied from a single 
dose to 6 months of regular use. Only one study considered postoper-
ative antibiotic prophylaxis to be necessary [9]. Two studies emphasized 
support and motivation for Valsalva and Politzer maneuvers during the 
follow-up [2, 8]. The findings are summarized in Table 1c.
Complications reported in these studies were few and minor. They in-
cluded minor bleeding, emphysema in the parotid region, hemotym-
panum, and temporary increase of tinnitus. They all resolved with 
time. In the studies that reported the rates of different complications, 
the rates ranged between 0.3% and 21%. 
Main Outcome Measures
No single outcome parameter was used in all the studies. Three 
studies reported that preoperatively 0%–28% of the patients could 
perform Valsalva maneuver, but one year postoperatively, 80%–98% 
could successfully perform it [2, 8, 11]. Additionally, the proportions of 
type B and C tympanograms reduced during the follow-up and that 
of type A increased [2, 8, 11]. Only two studies reported oto(micro)scopy 
results[8, 11]. In a study requiring normal tympanic membranes in otos-
copy for at least 6 months before the operation, all otoscopic findings 
remained normal during the follow-up [11]. Another study found that 
effusion decreased from 93% to 2%, but retraction and atelectasis 
remained unchanged (7%) at the end of the follow-up [8].
Xiong et al. [11] reported a positive change in tubomanometry for all 
three pressure levels (30, 40, and 50 mbar). Leichtle et al. found it 
difficult to perform tubomanometry in children and performed the 
measurement only with 50 mbar of pressure. They found greater pro-
portion of patients having normal R value (<1) postoperatively than 
preoperatively [2]. Two studies reported tubomanometry only as a 
part of ETS [9, 10]. 
ETS defined by Ockermann et al. [3], including tubomanometry at 
three pressure levels, subjective Valsalva, and clicking sound when 
swallowing, was reported in two studies [10, 11]. Xiong et al. [11] reported 
a significant improvement in ETS one year postoperatively. Schröder 
et al. also noted a significant improvement in ETS at 1, 2, and 3 years 
when compared with the preoperative ETS [10]. They could reach only 
two patients for follow-up 4 years after BET, and both patients had 
decreased ETS compared to the preoperative value. However, the 
patient population was not the same at 1, 2, 3, and 4 years postop-
eratively. Dalchow et al. developed a different ETS consisting of tym-
panometry and tubomanometry scores only [9]. Their scale ranged 
from 1 (the worst value) to 4 (the best value), and the mean value 
improved at one year postoperatively. However, they reported only 
ETS and no separate tympanometry or tubomanometry results, mak-
ing the comparison of their results with those of the other studies 
impossible. These findings are shown in Table 1d.
Table 1c. Other operations, corticosteroid treatment, and complications in studies with a follow-up of minimum 12 months
 Other operations in  Operations during Corticosteroids Other instructions 
Publication conjunction with BET follow-up pre/postop or medication Complications
Silvola et al.,  No TM perforation or Valsalva positive at 1 Nasal corticosteroid Valsalva 2 times/day; NR 
2014 [8] grommet → tympanostomy  month → grommet  for min 1 month if Valsalva negative 
  removal preoperatively and at 1 week, Politzer
  1 pt unable to do Valsalva  1 month maneuver → some 
  →	revision BET postoperatively could perform
  3 pt BET to contralateral side  Valsalva after that
  4 pt did not improve   
  → technetium scintigraphy  
  and for 3 of them explorative  
  tympanotomy and middle  
  ear endoscopy (one had  
  carotid dehiscence and  
  received no further  
  operations)   
Schröder et al.,  No Revision BET to 68/622 pt Nasal NR Emphysema in the parotid 
2015 [10]  marked as lost to corticosteroid  region (0.3%), minor bleeding, 
  follow-up for the  for 6 weeks  temporary increase of tinnitus, 
  first operation at the  postop  all resolved with time; 
  time of revision    insertion of balloon catheter  
     unsuccessful in 3 pt (4 ears)
Dalchow et al.,  Tympanoplasty to 124/342 pt Revision BET to 38/342 pt 250 mg prednisolone Cefuroxime 500 mg No 
2016 [9] before or in conjunction   on day 1 x2 for 5 days 
 with BET   postoperatively postoperatively  
Xiong et al.,  NR NR Nasal corticosteroid,  NR No 
2016 [11]   minimum 6 months  
   preoperatively  
Leichtle et al.,  BET+tympanocenthesis Revision BET (2 cases) NR Instructions and Hemotympanum (7%) 
2017 [2] (24 cases), tympanoplasty    motivation for resolved with time, minor 
 type I (5 cases), tympanoplasty    Valsalva and/or nasal bleeding (21%) resolved 
 type III (3 cases)   Politzer at every visit  with intranasal xylometazoline 
BET, balloon Eustachian tuboplasty; NR, not reported; pt, patient(s); TM, tympanic membrane
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Subjective Symptoms and Other Parameters
Three studies reported overall subjective symptoms which improved 
in 73%-98% of the patients [8, 10, 11]. Leichtle et al. [2] separately inves-
tigated the pressure in the ear, otalgia, and subjective hearing loss, 
and all these symptoms also showed a trend of improvement. Two 
years after BET, Schröder et al. [10] sent 89 patients (14%) an ETDQ-7, 
presumably with additional questions on subjective satisfaction, and 
30 patients (34%) returned the questionnaire. However, the study re-
ported no ETDQ-7 scores but only stated that 47% had no complaints 
and 26% experienced improvement. 
Single studies also used outcome measures such as mucosal inflam-
mation score [8], limitations in daily life [2], and general satisfaction, 
with the effect of BET [10]. Mucosal inflammation score and limitation 
in daily life diminished during the follow-up. At two years, 80% pa-
tients were at least partly satisfied with the treatment result [10]. None 
of the four studies [2, 9-11]. performing preoperative audiometry pre-
sented postoperative audiogram results. The findings are shown in 
Table 1e.
Studies With Follow-Up Period Of 6–11 Months
Study Characteristics
Five studies fulfilled all the other original inclusion criteria, but in-
stead of a minimum follow-up of 1 year, they had follow-up periods 
of 6–11 months. We analyzed these studies as additional information 
as only five studies fulfilled our inclusion criterion of 12-month fol-
low-up. Four of these five short-term studies were prospective. The 
level of evidence was 1b in one prospective randomized controlled 
trial [12] and 4 in the rest. Study populations ranged from 11 to 90 
patients (11–90 ears). The median follow-up, if reported, was 7–10 
months, and the follow-up time varied between 5 and 18 months. Of 
the five studies, two used Acclarent Relieva Solo catheter [13, 14], two 
used Spiggle & Theis [12, 15], and one used Acclarent Aera (Acclarent 
Inc., Menlo Park, CA, USA) [16]. The study characteristics and balloon 
sizes are indicated in Table 2a.
Inclusion and Exclusion Criteria and Preoperative Examination
Inclusion and exclusion criteria also varied between the short-term 
studies. In two studies, all patients had OME preoperatively [12, 13]. In 
one study, the inclusion criteria were or abnormal panogram and 
abnormal otoscopy [14]. One study required ETDQ-7>14.5 in order to 
treat ETD with BET [16] (Table 2b). A previous unsuccessful conserva-
tive treatment was a prerequisite in three studies [12, 14, 16]. Moreover, 
the preoperative investigations varied between the five studies. 
Other Operations, Corticosteroid Treatment, and Complications 
Three studies performed operations (other than BET) to at least 
a part of the study population in conjunction with BET [12-14]. These 
included tympanocenthesis, insertion or removal of tympanostomy 
tubes, myringoplasty, partial inferior turbinectomy, and other sinon-
asal operations. In one study, 6% of the study population received a 
revision BET during follow-up because of unimproved symptoms [14] 
(Table 2c).
Two studies reported corticosteroid treatment [13, 16]. One of them [13] 
advised nasal corticosteroid use for 1 month both preoperatively and 
postoperatively, and the other [16] instructed to use nasal corticoste-
roids for 3 months postoperatively. 
Objective Outcome Measures
As with the long-term studies, no single outcome parameter was 
used in all these short-term studies. Liang et al. randomized 90 pa-
tients with similar preoperative clinical status to three different 
Table 1d. Main outcome measures in studies with a follow-up period of minimum 12 months
 Valsalva positive Tympanometry type Oto(micro)scopy Tubomanometry ETS 
 (%, preoperatively →  (%, preoperatively →  (%, preoperatively →  (%, preoperatively → (mean value, preoperatively → 
Publication postoperatively) postoperatively) postoperatively) postoperatively) postoperatively)
Silvola et al.,  0 → 80, p<0.0001 A: 2 → 56 Normal: 0 → 90 NR NR 
2014 [8]  C: 24 → 15 Effusion: 93 → 2
  B: 15 → 0 Retraction/atelectasis: 7
  Open: 59 → 29 → 7
  p<0.0001 p<0.0001  
Schröder et al.,  NR NR NR Included in ETS 1 year ago: 
2015 [10]     3.13 → 5.75, p≤0.001 
     2 years ago:
     2.65 → 6.26, p≤0.001 
     3 years ago: 
     2.36 → 5.27, p≤0.05 
Dalchow et al.,  NR Included in ETS NR Included in ETS 2.23 → 2.68, p<0.05 
2016 [9]     (own ETS scale of 1–4)
Xiong et al.,  0 → 98, p<0.05 A:74 → 98 Normal: 100 → 100 R<1:  3.3 → 7.9, p<0.05 
2016 [11]  C: 26 → 2, p<0.05  30 mbar: 36 → 79, p<0.05
  B: 0 → 0   40 mbar: 43 → 86, p<0.05
    50 mbar: 50 → 90, p<0.05 
Leichtle et al.,  28 → 88 A: 14 → 50 NR 50 mbar: NR 
2017 [2]  C: 16 → 13*  R<1: 19 → 47
  B: 56 → 26  R=0: 51 → 15  
p-values taken from publications, if given. *, numbers estimated from a figure. ETS, Eustachian Tube Score; NR, not reported. 
117
Luukkainen et al. Outcome and Indications for BET
groups: group 1 received BET only, group 2 received BET and tym-
panocenthesis, and group 3 received tympanocenthesis only [12]. 
Tympanometry and otomicroscopy results were significantly better 
in group 1 and 2 than in group 3, in which they remained nearly un-
changed postoperatively. Results of group 2 were slightly better than 
those of group 1 but the difference between them was statistically 
insignificant. None of the short-term studies provided tubomanom-
etry or ETS results. Valsalva maneuver improved in 96%-100% [13, 16] 
and tympanometry normalized in 36%-97% [12-14, 16] of the study pop-
ulation. The review data are summarized in Table 2d.
Subjective Symptoms and Other Parameters 
Of the two studies reporting data from ETDQ-7, one [16] applied it 
separately to evaluate each ear, whereas the other [14] used it to eval-
uate both ears combined. The mean item score of ETDQ-7 improved 
from 4.9 to 2.0 and from 4.2 to 2.8 in these studies, respectively. The 
short-term studies provided no other information on overall symp-
toms. One questionnaire study investigated only general quality of 
life 6–18 months after BET using Glasgow Benefit Inventory (GBI) [15]. 
GBI showed significant improvement in the total score and in two 
subscores, ‘general health’ and ‘physical health’. 
One study used mucosal inflammation score as an outcome parameter 
and noted significant improvement in it after BET [13]. Another study 
applied the Sino-Nasal Outcome Test (SNOT-22) together with ETDQ-7 
and found a significant decrease also in SNOT-22 points [14]. None of 
the three studies that included preoperative audiometry presented 
postoperative audiogram results. Results of subjective symptoms and 
other miscellaneous parameters are reported in Table 2e.
Studies With Unclear Follow-Up Time
Some studies from our article search mentioned no duration of fol-
low-up at all. Others specified the follow-up time, but the time point 
when the presented results were obtained remained unclear. If we 
were unable to specify that the outcome was measured at least 6 
months or 1 year postoperatively for a certain amount of patients, we 
excluded the study from this report.
Dai et al. [17] prospectively followed eight patients (12 ears) for 3–15 
months after BET. They found that otomicroscopic findings normal-
ized in 71% patients by 6 months and proportion of type A and C 
tympanograms increased while that of type B tympanogram de-
creased during the follow-up. However, only five patients (seven 
ears) and two patients (three ears) were available for the analysis at 6 
Table 1e. Subjective symptoms and other measurements of studies with a follow-up period of minimum 12 months
Publication Symptoms ETDQ-7 Other
Silvola et al., 2014 [8] Improvement: 90% NR Mean mucosal inflammation score 2.8 → 1.4  
   (scale 1–4), p<0.0001
Schröder et al., 2015 [10] At 2 year 89 patients (154 ears),  NR At 2 year:  
 34% responded:   60% satisfied
 no complaints: 47%  20% completely satisfied only for the first few months
 improvement: 26%  20% dissatisfied
 no improvement: 27%  
Dalchow et al., 2016 [9] NR NR NR
Xiong et al., 2016 [11] Overall reduced in 98%;  NR NR
 Aural fullness disappeared in 83%;
 Aural fullness 8.2 (VAS 1–10 scale) → 1.3, p<0.05
 Muffled hearing (VAS) 6.7 → 1.5, p<0.05
 Otalgia (VAS) 5.2 → 1.9, p<0.05
 Tinnitus (VAS) 4.4 → 2.2, p<0.05  
Leichtle et al., 2017 2 Pressure in the ear: NR Limitation in daily life: 
 always: 59% → 4%  severe: 25% → 5%
 mostly: 24% → 6%*  moderate: 35% → 13% 
 sometimes: 6% → 10%*  low-grade: 23% → 11% 
 rarely: 5% → 48%*   no: 6% → 46% 
 never: 5% → 31%*   Totally or moderately satisfied: 73%
 Subjective hearing loss: 
 severe: 18% → 4%
 moderate: 19% → 4%*
 low-grade: 26% → 20%*
 slight: 21% → 35%*
 no: 16% → 37%
 Otalgia:
 always: 5% → 5%*
 mostly: 16% → 5%*
 sometimes: 18% → 16%*
 rarely: 29% → 37%*
 never: 31% → 37%*
p-values taken from publication if given. *, numbers estimated from a figure. ETDQ-7, Eustachian Tube Dysfunction Questionnaire; NR, not reported; VAS = Visual Analog Scale.
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and 12 months, respectively. Because of the small number of patients 
at 6 and 12 months, we excluded this study from our review. 
The Proposed Indications For Bet By The Finnish Otosurgical Society 
In the meeting of the Finnish Otosurgical Society in April 2016, we 
had a workshop with the objective of formulating national indica-
tions for BET. We reviewed the consensus statement on ETD [1] as well 
as the results of the long-term follow-up studies of BET published 
so far in English. Thereafter, we discussed 14 imaginary patient cases 
(Supplementary File 1) related to ETD, and the members of the soci-
ety individually voted on each case whether they thought BET was 
indicated or not. After each case, we discussed the results of the vote 
before proceeding to the next case. The voting results are shown in 
the Supplementary Table 1. On the basis of this workshop, the mem-
Table 2b. Inclusion and exclusion criteria and preoperative examinations of studies with a follow-up period of 6–11 months
Publication Inclusion criteria Exclusion criteria Preoperative examination
Poe et al., 2011 [13] Uni- or bilateral OME of min 5 years  NR Otomicroscopy, video endoscopy of the 
 (only improved with tympanostomy   ET with slow-motion review, mucosal  
 tubes or perforations)  inflammation score, tympanometry, and CT
McCoul et al., 2012 [14] Age>18 years, abnormal tympanogram  H&N surgery<3 months ago, radiotherapy ETDQ-7, SNOT22, clinical examination, 
 and abnormal otoscopy, ETD symtoms;  to H&N, sino-nasal carcinoma, acute tympanometry, audiometry, and CT of the 
 no response to 2-month therapy with  upper respiratory infection (also acute sinuses 
 per oral antihistamine, nasal corticosteroid, otitis media), hypertrophy of the adenoid 
 and Valsalva tonsil, nasal polyposis, cleft palate (also 
  previously operated), craniofacial 
  syndromes (also Down syndrome),  
  cystic fibrosis, dysmotile cilia, and 
  systemic immunodeficiency
Bast et al., 2013 [15] Chronic ETD treated with BET Contraindications for BET: age <18 years,  Clinical examination, tympanometry, 
  unidentifiable ET orifice, carotid dehiscence,  audiometry, and thin-layer CT 
  severe septal deviation, hyperplastic  
  turbinates, contraindications for general  
  anesthesia 
Liang et al., 2016 [12] Unilateral severe COME of minimum  Physiological defect of the ear or Otic endoscopic findings and 
 6 months (type B tympanogram and  nasopharynx, carotid dehiscence, tympanometry 
 otoscopic findings), refractory to  malformation, tumor or aneurysm in 
 treatments such as medications, Valsalva,  the ET or carotis interna, inability to 
 tympanocenthesis, and/or tympanostomies participate follow-up 
Bowles et al., 2017 [16] Clinical history of ETD and ETDQ-7 score  NR ETDQ-7, otoscopy, nasofiberoscopy, 
 >14.5 despite min 3-mo therapy with nasal   subjective Valsalva, tympanometry, and 
 corticosteroids, autoinflation devices, and   audiometry 
 Valsalva   
BET, balloon Eustachian tuboplasty; COME, chronic otitis media with effusion; CT, computed tomography; ET, Eustachian tube; ETD, Eustachian tube dysfunction; ETDQ-7, Eustachian 
Tube Dysfunction Questionnaire; H&N, head and neck; NR, not reported; OME, otitis media with effusion; SNOT-22, Sino-Nasal Outcome Test. 
Table 2a. Characteristics of studies with a follow-up period of 6–11 months
 Study Level of  n n Age (mean,  Follow-up Dilation instrument; 
Publication setting evidence (patients) (ears) years) [range] (months) [range] inflation pressure and time
Poe et al.,  Prospective 4 11 11 52 Median 7 [6–14] Acclarent Relieva Solo 7x16 mm; 
2011 [13] case series     [33–76]  7 cases 12 bar, 1 min
       4 cases 8–10 bar, 1 min
McCoul et al.,  Prospective 4 Total 22 35 55 Median 10 Acclarent Relieva Solo 5x24 mm 
2012 [14] case series  0–6 weeks: 22   [5–14] or 7x24 mm;
   12 weeks: 19    10 bar, 2 min
   6 months: 18     
Bast et al.,  Retrospective 4 30 NA 50 [6–18] Spiggle & Theis 3.3x20 mm; 
2013 [15] questionnaire     [24–73]  inflation pressure and time not 
 study      reported
Liang et al.,  Prospective 1b 90 90 No mean 6 Spiggle & Theis 3.3x20 mm; 
2016 [12] randomized     reported  10 bar, 2 min 
 controlled trial     [20–52] 
 (unblinded)      
Bowles et al.,  Prospective 4 39 55 46 6 Acclarent Aera 6x16 mm; 
2017 [16] case series    [19–74]  12 bar, 2 min
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Table 2c. Other operations, corticosteroid treatment, and complications in studies with a follow-up period of 6–11 months
 Other operations in  Operations during Corticosteroids  
Publication conjunction with BET follow-up pre/postop Complications
Poe et al.,  Tympanostomy if OME (18%), removal of No Nasal corticosteroid Contralateral C6-7 radiculopathy 
2011 [13] tympanostomy tube (27%)  1 month preoperatively  (9%), mucosal laserations (45%), all 
   and 1 month  resolved with time 
   postoperatively  
McCoul et al.,  Partial inferior turbinectomy to all, septoplasty Revision BET with a NR Bleeding from the turbinectomy site 
2012 [14] if required to reach the ET orifice (43%),  bigger balloon (6%)  → bilateral hemotympanum (3%) 
 sphenoetmoidectomy and antrostomy of the  because of symptoms  resolved with tympanocenthesis 
 middle meatus (34%), revision ethmoidectomy  at 6 months 
 (6%), revision sphenotomy (9%), removal of  
 clogged tympanostomy tube (3%),  
 myringoplasty (3%)   
Bast et al.,  No No NR NR 
2013 [15]    
Liang et al.,  According to randomization either no other NR NR NR 
2016 [12] operations than BET, tympanocenthesis +  
 BET or only tympanocenthesis   
Bowles et al.,  No No Nasal corticosteroid 3 No 
2017 [16]   months preoperatively 
BET, balloon Eustachian tuboplasty; ET, Eustachian tube; NR, not reported; OME, otitis media with effusion. 
Table 2d. Main outcome measures; follow-up 6–11 months
 Valsalva positive Tympanometry type Oto(micro)scopy   
 (%, preoperatively →  (%, preoperatively →  (%, preoperatively →    
Publication postoperatively) postoperatively) postoperatively) Tubomanometry ETS
Poe et al.,  0 → 100, p<0.001 A: 0 → 36 Grommet: 45 → 36 NR NR 
2011 [13] always: 64% C: 9 → 9 Perforation: 18 → 18
 sometimes: 36% B: 27 → 0 Atelectasis: 9 → 0
  Open: 64 → 55 Retraction: 9 → 0
   OME: 18 → 0
   Normal: 0 → 45  
McCoul et al.,  NR A: 0 → 97, p<0.001 NR NR NR 
2012 [14]  As: 29 → 0
  C: 57 → 0
  B: 14 → 3  
Bast et al.,  NR NR NR NR NR 
2013 [15]     
Liang et al.,  NR Only BET: Only BET: NR NR 
2016 [12]  A: 0 → 80 no effusion: 0 → 80
  C: 0 → 3 partial effusion: 0 → 7
  B: 100 → 17 complete effusion: 100 → 13
  BET + tympanocenthesis: BET + tympanocenthesis:
  A: 0 → 83 no effusion: 0 → 87
  C: 0 → 7 partial effusion: 0 → 7
  B: 100 → 10 complete effusion: 100 → 7
  Only tympanocenthesis: Only tympanocenthesis:
  A: 0 → 7 no effusion: 0 → 7
  C: 0 → 7 partial effusion: 0 → 7
  B: 100 → 87 complete effusion: 100 → 87 
Bowles et al.,  0 → 96 A: 40 → 95* NR NR NR 
2017 [16]  C: 26 → 2*
  B: 23 → 4*  
p-values taken from publication if given. *, numbers estimated from a figure. BET, balloon Eustachian tuboplasty; ETS, Eustachian Tube Score; NR, not reported; OME, otitis media 
with effusion. 
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bers of the society present in the meeting agreed on indications for 
BET. After the meeting, the indications were published on the soci-
ety’s web page and distributed to national ENT colleagues by e-mail. 
The Finnish Otosurgical Society’s members largely agreed with the 
guidelines provided in the consensus statement [1] concerning defi-
nition, types, clinical presentation, and diagnostics of ETD. The so-
ciety wanted to modify the diagnostic work-up so that also middle 
ear effusion would qualify as a sign of possible chronic dilatory ETD. 
The society recommends that to diagnose ETD, the patient should 
have both symptoms and clinical findings referring to ETD. These ear 
symptoms include a feeling of fullness, popping, discomfort or pain, 
pressure, clogged feeling, crackling, ringing, or muffled hearing. The 
evidence of a negative pressure in the middle ear should be reflected 
either as a negative pressure in tympanogram or as a serous middle 
ear effusion or retraction of the tympanic membrane in otomicrosco-
py. In case of baro-challenge-induced dysfunction, the diagnosis is 
based on the patient history as clinical status is usually normal in the 
normobaric circumstances of the office. 
Chronic rhinosinusitis, nasal polyposis, allergies, gastric reflux, or ad-
enoid hypertrophy should be treated first before considering BET. 
Also, the patients should be encouraged to quit smoking before pro-
ceeding to an operative treatment, even though we do not consider 
smoking as a contraindication for BET. We also agreed that patients 
should undergo tympanostomy before BET (excluding baro-chal-
lenge-induced dysfunction), as we considered that a positive result 
with the tympanostomy tube treatment suggests that the patient 
may benefit from BET. However, if patient has experienced no benefit 
from tympanostomy tubes, he/she is unlikely to benefit from BET. 
Based on the literature and expert opinion given by the society’s 
members, the Finnish Otosurgical Society recommends that BET 
may be considered when an adult patient has (i) chronic bothersome 
symptoms referring to ETD, (ii) ETD-related symptoms following rap-
id pressure changes, or (iii) recurring serous otitis media taking into 
account the above-mentioned conditions (Table 3). 
DISCUSSION
Studies on the effect of BET on chronic ETD are heterogeneous re-
garding patient selection, duration of follow-up, additional conser-
vative or operative treatments given, and outcome measures chosen. 
Trends in the improvement of symptoms and clinical findings after 
BET are evident, but for each particular outcome measure, only a 
couple of studies provide exact results. Therefore, a thorough com-
parison of all the studies selected for this review is impossible. 
During the preparation of this review, Huisman et al. published a sys-
tematic review and meta-analysis on the treatment of ETD with BET 
on the basis of an article search conducted in May 2016 [18]. Of the 103 
articles, 15 received critical appraisal. Because of the heterogeneity 
of the studies, meta-analysis was possible only for four outcomes. It 
revealed improvements in Valsalva maneuver, otoscopy, tympanom-
etry, and ETS in 3–9 studies. The review excluded studies with only 
children, and it included studies with follow-up as short as 5–6 weeks 
[19, 20]. As several studies have shown that the short-term outcome 
of BET is promising, we were interested in the long-term outcome, 
which is an important aspect when considering indications for BET. 
The effect of BET seems to vary depending on the outcome param-
eters used. In the studies with a minimum of 12-month follow-up, 
the Valsalva maneuver improved in 80%–98%, overall subjective 
symptoms in 73%–98%, otoscopic findings in 90%, tympanometry in 
24%–54%, and tubomanometry in 28%–43% of the patients (Table 
1d). Two studies with follow-up of 1–3 years presented an improve-
ment in ETS [2, 10]. Two years after BET, 80% of the patients were at 
least partly satisfied with the result (Table 1e), although only 34% (30 
of 89) of the patients responded to the questionnaire asking about 
satisfaction with the treatment result [10]. In another study, 73% of the 
patients (all children) were totally or moderately satisfied with the 
result one year after BET [2]. The limitation in daily life caused by ear 
symptoms [2] and mean mucosal inflammation score [8] reduced. Aural 
fullness disappeared in 83% of the patients and the severity of aural 
fullness, muffled hearing, otalgia, and tinnitus reduced significantly 
on Visual Analog Scale [11]. Feeling of pressure disappeared in 26%, 
subjective hearing loss in 21%, and otalgia in 6% [2] of the patients. 
Table 2e. Subjective symptoms and other measurements with a follow-up period of minimum 6 months
Publication Symptoms ETDQ-7 (symptom-specific mean,  
  preoperatively → postoperatively Other
Poe et al., 2011 [13] NR NR Mean mucosal inflammation score 2.91 → 1.73 (scale 1–4). p=0.003 
   View to ET lumen postoperatively: <4 mm if treated with 8 bar, at  
   least 4 mm but not up to isthmus if treated with 10 bar, isthmus  
   visible in 83 patients,33% of those who were treated with 12 bar,  
   p=0.004 (for full dilation associated with 12 bar) 
McCoul et al., 2012 [14] NR 4.5 → 2.8, p<0.001 SNOT-22 mean 51.4 → 30.0, p=0.001
Bast et al., 2013 [15] NR NR Improvement in total score (p = 0.001) and the subscores “general  
   health” (p=0.001) and “physical health” (p=0.039) of GBI 
Liang et al., 2016 [12] NR NR NR
Bowles et al., 2017 [16] NR 4.9 → 2.0, p<0.0001 NR
p-values taken from publication if given. ET, Eustachian tube; ETDQ-7, Eustachian Tube Dysfunction Questionnaire; GBI, Glasgow Benefit Inventory; NR, not reported; SNOT-22, 
Sino-Nasal Outcome Test.
Table 3. Indications for BET by the Finnish Otosurgical Society
1. Persistent and troublesome ETD symptoms in adults
2. Recurring SOM in adults
3. Difficulty to equalize pressure in the ears during rapid changes in 
atmospheric pressure in adults
ETD, Eustachian tube dysfunction; SOM, serous otitis media. 
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The results from the studies with 6–11 months of follow-up support 
these findings of a positive effect of BET (Table 2d and 2e). As indi-
cations for BET are inconsistent and the study populations differ in 
the analyzed studies, predicting the effect of BET on a certain patient 
group is impossible. Therefore, an open discussion with the patient 
on expected outcome of BET is an important part of preoperative 
counseling. However, BET seems to be a safe procedure not only in 
adults but also in children. No major complications arose, and even 
minor adverse effects were rare and were resolved during the fol-
low-up (Table 1c and 2c) [2, 8-18]. 
The balloon catheters used in these 10 studies were officially 3.2–7 mm 
in diameter and 16–24 mm in length (Tables 1a and 2a). It could be sug-
gested that a balloon with a larger diameter or a longer balloon would 
produce greater effect, but the longest catheter among the ones used 
here was the narrowest and the widest was the shortest. In the long-
term follow-up group, only one study used the Acclarent device (7 mm 
× 16 mm) [8], whereas four studies used the Spiggle & Theis catheter 
(3.2–3.3 mm x 20 mm) [2, 9-11]. The outcome measures vary greatly be-
tween these studies making comparisons difficult if not impossible at 
the moment. On the basis of our review, no trends of thicker or longer 
balloon dilation catheters producing better outcome are evident. In 
fact, Acclarent gives the length of the even middle part of the balloon, 
but the total length of the balloon is unspecified. However, the total 
length is quite close to that of the Spiggle &Theis balloon. 
One objective of treating ETD with BET is to avoid tympanostomies 
and other otosurgical operations. The cost of BET is significantly high-
er than that of a one-time tympanostomy. However, with repeating 
tympanostomies, the costs increase. The need for leave of absence 
from work in order to come to clinic and other related expenses 
should also be considered when considering the cost-effectiveness 
of BET versus repeated tympanostomies or other treatments. Howev-
er, there are no data available on the total costs of different treatment 
options. 
Liang et al. [12] showed that in 6 months of follow-up, the difference 
between results of BET with tympanocentesis and BET alone was 
insignificant. Tympanogram improved from type B to A in 83% of 
patients receiving BET along with tympanocenthesis and in 80% of 
those receiving BET only. Both groups showed significant improve-
ment as compared with the third group receiving only tympanocen-
thesis. However, the evidence to conclude if tympanocenthesis or 
tympanostomy has additional value to BET is insufficient.
In this review, two studies used specific outcome measures that were 
applied only in the given study [9, 15]. These seldom used parameters 
also yield important information but comparing them to some com-
monly agreed clinical tests would enhance the benefit of the results 
for clinical work. Therefore, it would be important to agree on defi-
nitions and diagnostic parameters of ETD and perform future long-
term studies with more uniform outcome measures. Schilder et al. 
[1] suggested using symptoms, otoscopy, tympanometry, and pure 
tone audiometry as outcome measures in future studies. Smith et 
al. [21] studied the reliability of eight tests for ET function and found 
tubomanometry to be superior. However, they concluded that a sin-
gle measurement of any clinical test is inadequate in assessing the 
opening of the ET, and repeating the chosen tests a few times im-
mediately might be helpful. Combining tubomanometry with other 
clinical tests (as in ETS-7, for example) and numeric symptom evalu-
ation (as in ETDQ-7) seems tempting, but no such composite scores 
exist till date. There is clearly room for methodological improvement 
in this respect. 
Three long-term studies [8, 9, 11] and three studies with 6 to 11-months 
of follow-up [13-15] performed CT scans preoperatively mainly to ex-
clude the possibility of damage to the internal carotid artery. With 
this intent, CT scan seems to be unnecessary [1, 22]. However, some 
anomalies, such as superior semicircular canal dehiscence or large 
vestibular aqueduct, may mimic ETD symptoms and are visible in CT 
scans. CT scans may also be useful in case of problems with insertion 
of the catheter. Thus, CT may be helpful in selected cases. 
The Finnish Otosurgical Society agreed on indications for BET in its 
meeting in April 2016. Our indications for BET are (i) chronic bother-
some symptoms referring to ETD, (ii) ETD-related symptoms follow-
ing rapid pressure changes, or (iii) recurring serous otitis media. With 
the current evidence, we suggest using BET for treating only adult 
patients with ETD. The patient should also have previous positive 
experience from tympanostomy tube (excluding baro-challenge-in-
duced dysfunction). In our experience, if the patient experiences no 
benefit from tympanostomy tubes, he/she is unlikely to benefit from 
BET. We suggest treating chronic rhinosinusitis, nasal polyposis, aller-
gies, gastric reflux, or adenoid hypertrophy prior to BET treatment. 
We also strongly encourage patients to quit smoking. 
Randomized placebo-controlled studies are needed to show the true 
long-term effect of BET. The effect of the balloon size, nasal patholo-
gy, inflammation of the ET mucosa, and some other parameters such 
as patient’s body mass index need to be studied more thoroughly.
CONCLUSION
Five studies with at least 12-month follow-up fulfilled the inclusion 
criteria of this review. They suggest that the long-term outcome of 
BET is promising: Valsalva improved in 80%–98%, overall subjective 
symptoms in 73%–98%, and otoscopic findings in 90% of the pa-
tients. Tympanometry and tubomanometry clearly improved less, 
in 24%–54% and 28%–43% patients, respectively. Moreover, ETS 
improved for up to 3 years after treatment with BET. Five additional 
studies with a follow-up of 6–11 months support the findings from 
the long-term studies. However, more controlled prospective studies 
with long-term (>12 months) follow-up and more uniform outcome 
measures are needed.
On the basis of a workshop at the annual meeting in 2016, the Finnish 
Otosurgical Society outlined indications for BET. Our indications for 
BET in adult patients are (i) chronic bothersome symptoms referring 
to ETD, (ii) ETD-related symptoms in conjunction with rapid pressure 
changes, or (iii) recurring serous otitis media. At this point, with the 
lack of evidence, we do not suggest regularly providing BET as treat-
ment for children with ETD. No international indications for BET ex-
ist and, to the best of our knowledge, these are the first established 
indications for BET outlined by a national otosurgical society. These 
indications will hopefully help clinicians treating ETD patients. They 
will also provide equality in terms of patient care as well as promote 
research on ETD and BET by unifying clinical practices.
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Supplementary File 1: 
Exemplary patient cases for voting and discussing indications for BET 
in the annual meeting of the Finnish Otosurgical Society, April 2016
Case 1
History: An otherwise healthy 42-year-old woman presented with a 
subjective hearing loss and constant clogged feeling in her both ears. 
She had a history of few otitis media and experienced pressure and pain 
in the ears for weeks in association with common colds. Previously, the 
symptoms had improved with tympanostomy tubes but now she wish-
es not to have more tubes because she swims as a hobby. 
Clinical status: Translucent tympanic membranes with slight retrac-
tion and negative Valsalva on both sides of the ear. The nasopharynx 
is normal. Audiogram reveales normal hearing.
Case 2
History: An otherwise healthy 32-year-old man experienced a few 
otitis media in childhood. He works as a flight attendant and expe-
riences severe pain in the ears during takeoffs and landings; he has 
had two secretory otitis media and two perforations of tympanic 
membrane in history. Previous therapy with local xylometazoline, 
mometasone, and a combination of acrivastine and pseudoephed-
rine had little effect on the symptoms. He experiences no subjective 
hearing impairment.
Clinical status: Tympanic membranes are translucent and easily mov-
able, without retraction. The nasophrarynx is normal, and the ET ori-
fices are open. Rinne test -/-, Weber test shows no lateralization. 
Case 3
History: An otherwise healthy 7-year-old boy has had tympanostomy 
tubes inserted twice because of recurrent otitis media. None of the 
tubes are now in place, and the otitis media episodes keep recurring. 
Clinical status: The tympanic membranes are translucent and easily 
movable, without any retraction. The nasopharynx is normal, and the 
ET orifices are open. An audiogram reveales normal hearing. 
New tympanostomy has been scheduled.
Case 4
History: An otherwise healthy 37-year-old man has had seven otitis 
media episodes and two tympanic membrane perforations in the 
right ear during the last 4 years. He always feels pressure and pain in 
the right ear during episodes of common cold. He has no ear symp-
toms in the absence of a common cold. 
Clinical status: Right ear: a secondary membrane detected in the low-
er part of the tympanic membrane, which is easily movable and has a 
slight retraction. Left ear: normal. Valsalva -/+. An audiogram reveales 
normal hearing.
Case 5
History: An otherwise healthy 4-year-old girl has had recurring se-
cretory otitis media on both sides since she was 2 years old, with a 
recurrence immediately when the tympanostomy tubes fall out. Ad-
enotomy was performed earlier and no residual adenoid tonsil was 
present when the nasopharynx was checked in conjunction with last 
tympanostomy. Her teenage sister has had tympanostomy tubes in-
serted 15 times, and she still has recurring secretory otitis media. 
Clinical status: Tympanic membrane retractions and thick mucous se-
cretions are observed in both ears. The patient breathes through her 
nose, but her hearing seems to be impaired. 
Her mother has asks if anything else could be done in addition to 
inserting new tubes.
Case 6
History: An otherwise healthy 25-year-old woman has had frequent 
tympanostomies because of secretory otitis media since childhood. 
She received adenotonsillectomy earlier, but now the tubes have fall-
en out; both her ears remain clogged following a common cold. She 
is completely tired of repetitive tympanostomies and tubes in her 
ears. The nasal corticosteroid treatment provided no improvement. 
Clinical status: Tympanic membrane retractions present in both ears, 
with sclerosis in the lower parts. Mucous secretion observed behind 
the tympanic membranes. The nasopharynx is normal, and the orific-
es of the ETs are open. Audiogram shows conductive hearing loss on 
both sides with PTA 35/35 dB.
A new tympanostomy is being suggested, but could BET be consid-
ered as treatment?
Case 7
History: An otherwise healthy 33-year-old woman experiences pres-
sure and clogged feeling in the ears as well as tinnitus during com-
mon cold. She has a few episodes of otitis media in the history. She 
swims regularly. 
Clinical status: Translucent tympanic membranes are observed. Poste-
rior retraction of pars tensa on both sides, but it moves with pneumatic 
otoscopy. Valsalva -/-. The nasopharynx is normal. A slight conductive 
hearing loss is detected in both ears in audiogram, PTA 25/25 dB.
Case 8
History: An otherwise healthy 33-year-old woman experiences pres-
sure and clogged feeling in the ears as well as tinnitus during com-
mon cold. She has had few otitis media episodes in the past and does 
not swim.
Clinical status: She has translucent and easily movable tympanic 
membranes. No retractions are observed in the pars tensa on either 
side but deep retractions are seen in pars flaccida on both sides with-
out any deposits in the retractions. Valsalva +/+, Toynbee +/+. The 
nasopharynx is normal; the audiogram reveales normal hearing.
Case 9
History: An otherwise healthy 57-year-old man presented with an 
otitis media and tympanic membrane perforation in the right ear 6 
months ago. The perforation has not healed yet. 
Clinical status: Right ear: a central perforation is observed in the low-
er anterior part of the tympanic membrane; the middle ear is normal 
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with no secretion. Left ear: the tympanic membrane is translucent 
with no retraction. Valsalva -/-. The nasopharynx is normal. A conduc-
tive hearing loss is detected on the right in the audiogram. 
Case 10
History: An otherwise healthy 57-year-old man had an otitis media 
and tympanic membrane perforation on the right 4 years ago. My-
ringoplasty with fascia was performed 3 years ago but a new perfora-
tion appeared. Another myringoplasty with cartilage and perichon-
drium was performed two years ago. One year ago, the perforation 
appeared again. The patient has triathlon as a hobby.
Clinical status: Right ear: a perforation along the border of the 
tympanic membrane in the anterior lower part and anterior to the 
cartilage inserted earlier is observed. The tympanum is free of any 
secretion. Left ear: translucent the tympanic membrane is in the 
normal position. Valsalva indifferent/+. Nasopharynx is normal, 
and a slight conductive hearing loss on the right is detected in the 
audiogram.
Case 11
History: An otherwise healthy 57-year-old man presented with an 
otitis media 2 years ago for the first time in his life and had a perfora-
tion of the tympanic membrane on the right. After that, he has had 
five episodes of purulent secretion from the right ear. 
Clinical status: Right ear: a thick tympanic membrane with central 
perforation is observed in the lower part. The mucous membrane of 
the middle ear is swollen and moist. Left ear: a translucent and easily 
movable tympanic membrane is in the normal position. Valsalva -/-. 
A conductive hearing loss is observed on the right in an audiogram.
Case 12
History: An otherwise healthy 25-year-old woman has underwent 
repetitive tympanostomies because of secretory otitis media since 
childhood. She has received adenotonsillectomy. During the past 
years, the tubes have stayed in place only for a very short time. 
Clinical status: Adhesive tympanic membranes are present on both 
the sides. Valsalva -/-. Normal nasopharynx. The orifices of the ETs are 
open. A conductive hearing loss is detected on both sides in the au-
diogram, PTA 43/43 dB.
Case 13
History: An otherwise healthy 33-year old woman had a secretory oti-
tis media in her childhood and had no ear complaints after that for a 
long time. The right ear became clogged 6 months ago.
Clinical status: Right ear: retraction cholesteatoma is seen in the pos-
terosuperior part of the pars tensa. Left ear: a retraction is observed 
in the posterior part of the part tensa. Valsalva -/+. The nasopharynx 
is normal. A marked conductive hearing loss is observed on the right 
in the audiogram, PTA 45/12 dB. A CT scan revealed an eroded pro-
cessus longus of the incus with soft tissue around it; shadowing con-
tinuing to the mastoid is also observed.
You have planned a tympanomastoidectomy. But should BET be per-
formed before that?
Case 14
History: An otherwise healthy 33-year-old woman had secretory oti-
tis media in childhood and no ear complaints for a long time after 
that. Her right ear became clogged 6 months ago.
Supplementary Table 1. Voting results on patient cases
 Specialists routinely performing Specialists not routinely performing 
 BET (n=15) BET (n=6) ENT Residents (n=5)
   Unable to    Unable to   Unable to 
Case Yes (n%) No (%) decide (%) Yes (n%) No (%) decide (%) Yes (n%) No (%) decide (%)
1 87 0 13 67 17 17 100 0 0
2 100 0 0 67 17 17 100 0 0
3 0 87 13 0 100 0 0 100 0
4 69 13 19 17 33 50 60 0 40
5 0 100 0 0 100 0 0 100 0
6 93 0 7 100 0 0 100 0 0
7 13 38 50 0 67 33 0 0 100
8 0 93 7 0 100 0 0 100 0
9 0 100 0 0 100 0 0 100 0
10 73 7 20 33 50 17 0 0 100
11 0 100 0 0 100 0 0 100 0
12 7 93 0 0 100 0 0 100 0
13 0 88 13 0 71 29 0 20 80
14 33 40 27 14 71 14 0 20 80
For each patient case (for the description of the cases, see Supplementary File 1), the members of the Finnish Otosurgical Society and the residents present in the meeting voted if 
they thought that BET was indicated or not or whether they were unable to decide. The votes were divided to three groups according to if the person voting was an ENT specialist 
routinely performing BET, an ENT specialist not routinely performing BET, or an ENT resident. 
BET, balloon Eustachian tuboplasty.
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Clinical status: Right ear: a retraction cholesteatoma is seen in the 
posterosuperior part of the pars tensa. Left ear: a retraction is ob-
served in the posterior part of part tensa. Valsalva-/+. The naso-
pharynx is normal. A marked conductive hearing loss on the right is 
recorded in the audiogram, PTA 45/12 dB. A CT reveales an eroded 
processus longus of the incus with soft tissue shadowing around it; 
the soft tissue shadowing continues to the mastoid.
You have planned a tympanomastoidectomy. But should BET be per-
formed in conjunction with it?
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